 Saint- Herb lain France , October 10 , 2 02 2 Valneva SE Nasdaq: VALN; Euronext Paris: VLA, a specialty vaccine company, announces today it will present on its single-shot chikungunya vaccine candidate at several leading scientific conferences during the fourth quarter of 2022. 